AstraZeneca hikes dividend after strong finish to the year
Q4 sales and earnings beat consensusTotal dividend raised by 7% to $3.10Double-digit 2025 EPS growth targetShares in mega-cap pharmaceutical maker AstraZeneca (AZN) leapt to the top of the FTSE 100 leader board, gaining almost 5%...
06 February 2025